Nanovis
Nanovis is a technology-driven company committed to discovering unmet clinical needs, developing innovative and enabling solutions, and validating new technologies for clinical and market acceptance. Founded in 2008 by Brian Emerick and licensed intellectual property from Purdue Research Foundation, Nanovis has become the market leader in nanotechnology used to improve the biological response of implanted orthopedic devices. Through its subsidiary Nanovis Spine, Nanovis commercialized its proprietary bioceramic nanotube surface on a family of spinal implants include enhanced PEEK interbodies with porous titanium endplates and pedicle screws. Nanovis is working to add a bactericidal capability to our fixation technologies as well as technology to treat and prevent localized infections, even those caused by some of the most virulent and deadly antibiotic resistant bacteria in the world today.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About Us
Nanovis' Vision
Be the best at harnessing science and nanotechnology to create and sell clinically and meaningfully superior implants
Innovate
We will empower the Nanovis team and collaborate with external partners to provide innovation that provides clinically differentiated outcome
Discover
Research unmet clinical needs that need effective and economic solutions down arrow
Innovate
Innovation throuh collaboration to develop science driven technology platforms
Validate
Science, Regulatory, Scalable Manufacturing Processes, Market Advantages
Transition
Transition technology to partner and repeat with new technology platforms